KFGK
BRTX icon

Keystone Financial Group (Kentucky)’s BioRestorative Therapies BRTX Stock Holding History

Keystone Financial Group (Kentucky)’s Portfolio BRTX Stock Details BRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Buy
+28,600
New +$8.37K ﹤0.01% 564

Other funds holding BRTX

VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
WA
Wealth Alliance Mellville, New York $1.2B AUM 26.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Keystone Financial Group (Kentucky)'s BRTX Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) opened a new position in BioRestorative Therapies (BRTX) in Q2 2026: 28,600 shares worth $10.8K. The stake represents ﹤0.01% of the portfolio and ranks #564 among its holdings.

15 funds tracked by Wall St. Rank hold BRTX as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 28,600 shares of BioRestorative Therapies worth $10.8K as of Q2 2026.
  • BioRestorative Therapies was a new Keystone Financial Group (Kentucky) position in Q2 2026.
  • BioRestorative Therapies made up ﹤0.01% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #564 holding.
  • 15 funds tracked by Wall St. Rank held BioRestorative Therapies as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.